Elos Medtech signs a global distribution agreement of selected products with Nobel Biocare. Elos Medtech and Nobel Biocare have been business partners over 25 years, mainly within contract-manufacturing, and are now expanding the collaboration within the growing market of digital dentistry.
By this global distribution agreement, Nobel Biocare's prosthetic product portfolio is extended with a private labelled product from the Elos Accurate[®] product family. The agreement also includes Elos Accurate[ ]Analog for Printed Models as third-party product, compatible with multiple dental implant systems. The products are now available through Nobel Biocare and its distributors.
Together, Nobel Biocare and Elos Medtech offer more options in the digital workflow, both regarding more implant restoration possibilities and more manufacturing opportunities for the laboratory. The extended collaboration allows for simplicity and efficiency for dentists and laboratories since the products are within the same workflow.
"We are excited that Nobel Biocare have chosen to expand our partnership and to be able to continue demonstrating our commitment and dedication in providing dental professionals worldwide with world-class products. Enabled by our proprietary products, Nobel Biocare can effectively expand its product portfolio and offer dental professionals more options in the digital workflow", says Søren Olesen, Global Business Director Dental, Elos Medtech. "We will continue our ongoing collaboration to further expand workflow options for our customers in the future", concludes Søren Olesen.
About Nobel Biocare
Nobel Biocare is a world leader in the field of innovative implant-based dental restorations. The company's portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems (including key brands NobelActive[®], Brånemark System[®] and NobelReplace[®]), a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems (NobelProcera[®]), diagnostics, treatment planning and guided surgery solutions (NobelClinician[®] and NobelGuide[®]) and biomaterials (creos™). Nobel Biocare supports its customers through all phases of professional development, offering world-class training and education along with practice support and patient information materials. The company is headquartered in Zurich, Switzerland. Production takes place at six sites located in the United States, Sweden, Japan and Israel. Products and services are available in over 80 countries through subsidiaries and distributors.
About Elos Medtech
Elos Medtech is a leading development and production partner for medical devices and components, with a focus on dental and orthopedic implants and instruments. The company operates from facilities in Sweden, Denmark, China and the US. The customer base comprises international medical technology companies.
Elos Medtech has more than 550 employees and a turnover of more than SEK 600 million. Elos Medtech has been listed on NASDAQ Stockholm AB since 1989. Elos Medtech's B share is categorized as a Health Care company on the Small Cap list.
Gothenburg, December 19, 2019
Elos Medtech AB (publ)
For further information, please contact:
For additional information about the Elos Medtech Group, visit www.elosmedtech.com
For additional information about the Elos Dental Solutions, visit www.elosdental.com
This information was distributed by Cision http://www.cisionwire.se/